What's new concerning the management of acne? Find out in this easy-to-navigate collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Background: Acne is one of the ...

Acne vulgaris refers to the pimples, blackheads, or just the “acne” that may break out on your skin. Over-the-counter (OTC) treatments, prescription medication, and lifestyle changes can help ...

Acne vulgaris is a chronic inflammatory disease — rather than a natural part of the life cycle as colloquially viewed — of the pilosebaceous unit (comprising the hair follicle, hair shaft and ...

DelveInsight's “Acne Vulgaris Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Acne Vulgaris, historical and forecasted ...

Acne vulgaris is a common skin disease affecting all ages. Antibiotics remain the most common prescribed agent for the treatment of acne. Improper use of antibiotics in the dermatological setting ...

nonusers. Women were 53% more likely to develop acne vulgaris 1 year after starting the drug. Glucagon-like peptide-1 receptor agonists, an increasingly popular class of weight loss medications ...

Acne vulgaris (acne) is a chronic, inflammatory skin disease characterized by papules, pustules and nodules arising on the face, chest and back. These clinical features reflect underlying ...

Acne vulgaris occurs when hair follicles become clogged with excess sebum — an oily substance from your skin — and dead skin cells. The plugged follicles can become inflamed with an increase ...

LAVAL, QC / ACCESSWIRE / April 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that its topical prescription treatment for acne ...

Image Credit: Boyloso/Shutterstock.com Rosacea and acne vulgaris are common skin conditions that require appropriate foods to complement treatment regimens. Assessing the influence of diet on ...

The first FDA-approved acne drug with a first-in-class mechanism of action in nearly 40 years launched in the United States in November 2021 after being approved in August 2020. The first-in-class ...

Clascoterone cream 1% caused mild, reversible hypothalamic-pituitary-adrenal axis suppression under maximum-use exposure in patients with acne vulgaris, according to a study. “The FDA looked at ...